GenScript Bio (01548): CARVYKTI generated approximately $555 million in net sales for the fourth quarter.

21:01 21/01/2026

Kingsway Biotech (01548) released an announcement that, based on the cooperation and licensing agreement signed between Legend and Janssen Biotech, Inc. on December 21, 2017, CARVYKTI is expected to generate approximately $555 million in net sales from trade by the end of the quarter ending December 31, 2025.

GENSCRIPT BIO (01548) announced that, based on the collaboration and licensing agreement established with Legend and Janssen Biotech, Inc. (Johnson & Johnson) on December 21, 2017, CARVYKTI generated approximately 550 million US dollars in net sales in the quarter ending December 31, 2025.

Ningbo Shanshan (600884.SH) may see a change in its controlling shareholder to Wanwei Group.

Broad strategy: A-shares may usher in a new round of upward cycle in the future.

Zhejiang Tenchen Controls' subsidiary has become a supplier of passenger car seats for a domestic automotive company in China.

Ningbo Shanshan (600884.SH) may see a change in its controlling shareholder to Wanwei Group.

Broad strategy: A-shares may usher in a new round of upward cycle in the future.

Zhejiang Tenchen Controls' subsidiary has become a supplier of passenger car seats for a domestic automotive company in China.